title: Long-term effect of low-dose folic acid intake: potential effect of mandatory fortification on the prevention of neural tube defects.
abstract: BACKGROUND
  Understanding the full effect of chronic low-dose folic acid is important in interpreting the effect of the mandatory folic acid fortification program in North America.
  
  
  OBJECTIVE
  We aimed to describe the rate of attainment and steady state (plateau) of red blood cell (RBC) folate in response to long-term intake of 140 μg (designed to mimic fortification) and 400 μg (recommended dose for the primary prevention of neural tube defects) folic acid/d in reproductive-aged women living in a country with minimal fortification.
  
  
  METHODS
  On the basis of pharmacokinetics principles, it was recently proposed that a steady state should be reached after 40 wk. Thus, 144 women aged 18-40 y were randomly assigned to receive a daily folic acid supplement of 140 (n = 49) or 400 (n = 48) μg or placebo (n = 47) for 40 wk. RBC folate was measured at baseline and at 6, 12, 29, and 40 wk.
  
  
  RESULTS
  After 40 wk, RBC folate did not reach a plateau in either treatment group. Kinetic modeling of the data indicated that RBC folate would approximately double from 779 to 1356 nmol/L in response to 140 μg folic acid/d with only ≈50% of model-estimated steady state conditions achieved at 40 wk. An average RBC folate concentration of 1068 nmol/L after 12 wk of supplementation with 400 μg folic acid/d was readily achieved at 36 wk after continuous intake of 140 μg/d.
  
  
  CONCLUSIONS
  Our model shows the considerable length of time required to attain the full effect of low-dose folic acid, which suggests that 140 μg folic acid/d could be as effective as 400 μg folic acid/d taken during the periconceptional period if given sufficient time. This trial is registered at www.anzctr.org.au as ACTRN12609000215224.
authors: Departments of Human Nutrition and Preventive and Social Medicine, University of Otago, Dunedin, New Zealand. lisa.houghton@otago.ac.nz
authors: Lisa A
authors: LA
authors: Houghton
authors: Andrew R
authors: AR
authors: Gray
authors: Meredith C
authors: MC
authors: Rose
authors: Jody C
authors: JC
authors: Miller
authors: Nicola A
authors: NA
authors: Hurthouse
authors: Jesse F
authors: JF
authors: Gregory
references: Am J Epidemiol. 2009 Jan 1;169(1):9-17
references: 18953063
references: J Nutr. 2002 Nov;132(11):3353-5
references: 12421850
references: Am J Clin Nutr. 2007 Nov;86(5):1414-9
references: 17991654
references: N Engl J Med. 1992 Dec 24;327(26):1832-5
references: 1307234
references: Am J Clin Nutr. 2008 Aug;88(2):448-57
references: 18689382
references: Am J Epidemiol. 2009 Jan 1;169(1):18-21; discussion 22-3
references: 18953060
references: Am J Clin Nutr. 2010 Oct;92(4):818-25
references: 20739423
references: Am J Clin Nutr. 2007 Dec;86(6):1773-9
references: 18065598
references: N Engl J Med. 1999 Nov 11;341(20):1485-90
references: 10559448
references: JAMA. 1995 Dec 6;274(21):1698-702
references: 7474275
references: Nutrients. 2011 Jan;3(1):49-62
references: 22254076
references: JAMA. 1989 Nov 24;262(20):2847-52
references: 2478730
references: Lancet. 1991 Jul 20;338(8760):131-7
references: 1677062
references: Annu Rev Nutr. 2002;22:199-220
references: 12055343
references: Am J Clin Nutr. 2006 Jul;84(1):156-61
references: 16825690
references: Am J Clin Nutr. 2003 Apr;77(4):919-23
references: 12663292
references: JAMA. 1988 Dec 2;260(21):3141-5
references: 3184392
references: Am J Clin Nutr. 2010 Jan;91(1):231-7
references: 19923379
references: J Nutr. 1998 Nov;128(11):1896-906
references: 9808640
references: JAMA. 1993 Mar 10;269(10):1257-61
references: 8437302
references: Am J Med Genet. 1996 Jan 2;61(1):30-6
references: 8741914
references: J Nutr. 1995 Oct;125(10):2717-25
references: 7562109
references: Epidemiology. 1995 May;6(3):219-26
references: 7619926
references: Methods Enzymol. 1997;281:43-53
references: 9250965